Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434

Barchart · 1d ago

– Newly granted patent extends protection for ATH434 to at least 2045, 
significantly enhancing its strategic value and long-term commercial potential –

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.